-
Highlights from Day 3
November 15, 2025Below you can review some of the key topics covered at the EMUC25 Congress today. We share webcasts, session...
00 -
Treatment challenges in MIBC: ctDNA, EV-P cost and access
November 15, 2025In his EMUC25 lecture ‘ctDNA in muscle-invasive bladder cancer: Ready for prime time?’ Prof. Lars Dyrskjøt (DK) shared data...
-
EMUC25 examines BRCA and PRS in hereditary GU cancers session
November 15, 2025What are the current updates regarding the significantly elevated prostate cancer (PCa) risk in individuals with BRCA mutations? What...
-
The big PCa game-changers for 2025
November 15, 2025In an auditorium packed to capacity, Dr. Elena Castro (ES), Prof. Axel Merseburger (DE), and Dr. Alison Tree (GB),...
-
EMUC25: Day 2 highlights
November 14, 2025Check out some highlights below from Day 2 at EMUC25, including session reports, webcasts, award winners and photo impressions....
-
Strategies in NMIBC: BCG failure, biomarkers and cost-effective treatments
November 14, 2025Following lively multidisciplinary case discussions in Plenary Session 4 at EMUC25, which covered multiple carcinoma in situ (CIS), as...
-
Highlights from Day 1 at EMUC25
November 13, 2025Interested in the recap of today’s coverage on urological imaging? Explore the highlights of Day 1 of the EMUC25 Congress. Session report:...
-
Controversial issues in urological pathology: a multidisciplinary approach
November 13, 2025At the European Society of Uropathology – EAU Section of Urological Research (ESUP-ESUR) Symposium on Day 1 of EMUC25,...
-
The future of finding cancer: Detecting earlier
November 13, 2025During the second session by the EAU Section on Urological Imaging on Day 1 at EMUC25 in Prague, presenters...
-
No compromises: GU-cancer care can be effective, equitable, accessible, and sustainable by 2050
September 3, 2025This year’s 17th European Multidisciplinary Congress on Urological Cancers (EMUC25) will tackle one of the most pressing questions in...
